Skip to main content
OpenTrials
Completed

NCT Number: NCT01470638

A Study of Flt3-Ligand Levels in Sjögrens Syndrome

The study aims to correlate levels of Flt3-ligand in Cerebrospinal Fluid (CSF) and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The study aims to correlate levels of Flt3-ligand in CSF and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • fulfill the ACR-criteria for primary Sjogrens syndrome,
  • age above 18 years old

Exclusion criteria

  • other CNS-disease

Treatment and study plan

Primary outcomes

  1. Correlate levels of Flt3-ligand in Cerebrospinal Fluid (CSF) and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome

    Time frame: June 2009 - June 2015

Sponsors and collaborators

Lead sponsor

Göteborg University

Other

Registry information

Official study title

Analyzes of Cerebrospinal Fluid in Autoimmune Systemic Diseases

Important dates

Study start
2009
Primary completion
2019
Study completion
2019
First posted
Nov 11, 2011
Registry last updated
Apr 24, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.